Evaluating the Diagnostic Performance of Systemic Immune-Inflammation Index in Childhood Inflammatory Arthritis: A Focus on Differentiating Juvenile Idiopathic Arthritis from Reactive Arthritis
- PMID: 38255172
- PMCID: PMC10812990
- DOI: 10.3390/biomedicines12010065
Evaluating the Diagnostic Performance of Systemic Immune-Inflammation Index in Childhood Inflammatory Arthritis: A Focus on Differentiating Juvenile Idiopathic Arthritis from Reactive Arthritis
Abstract
In pediatric care, the range of potential diagnoses for arthritis can be relatively extensive, primarily involving infectious and inflammatory causes and, to a lesser extent, oncological conditions. Specifically, when addressing inflammatory causes, differentiating between Juvenile Idiopathic Arthritis (JIA) and Reactive Arthritis (ReA) can prove to be challenging during the first weeks, owing to the lack of specific antibodies in several JIA subtypes. This single-center retrospective study of 108 children with arthritis aimed to evaluate in greater detail the complete blood count (CBC) profiles of children with JIA and ReA in greater detail. The most significant differences were noted in terms of the Systemic Immune-Inflammation Index (SII), with higher values in the JIA group. Moreover, within the JIA group, SII displayed a significant positive correlation with conventional inflammatory biomarkers, specifically C-reactive protein (ρ = 0.579) and Erythrocyte Sedimentation Rate (ρ = 0.430). It was the only independent factor associated with the presence of JIA after adjusting for age (p = 0.030). Also, even with the moderate diagnostic value, the discriminating capacity of SII was superior to those of each of its component CBC parameters according to receiver operating characteristic (ROC) analysis. In summary, this study identified elevated SII values in the JIA group compared to the ReA group, indicating the potential utility of SII as an adjuvant discriminatory marker between these two arthritis forms.
Keywords: complete blood count; inflammation; juvenile idiopathic arthritis; reactive arthritis; systemic immune-inflammation index.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Analysis of childhood reactive arthritis and comparison with juvenile idiopathic arthritis.Clin Rheumatol. 2005 Aug;24(4):388-93. doi: 10.1007/s10067-004-1042-0. Epub 2004 Dec 10. Clin Rheumatol. 2005. PMID: 16034649
-
Examining the Relationship between Systemic Immune-Inflammation Index and Disease Severity in Juvenile Idiopathic Arthritis.Cells. 2024 Mar 3;13(5):442. doi: 10.3390/cells13050442. Cells. 2024. PMID: 38474406 Free PMC article.
-
The Importance of Differentiating Oligoarticular Juvenile Idiopathic Arthritis From Lyme Arthritis in Pediatric Patients.Cureus. 2022 Dec 21;14(12):e32785. doi: 10.7759/cureus.32785. eCollection 2022 Dec. Cureus. 2022. PMID: 36694509 Free PMC article.
-
Kidney function and renal resistive index in children with juvenile idiopathic arthritis.Clin Exp Med. 2023 Jul;23(3):759-766. doi: 10.1007/s10238-022-00898-x. Epub 2022 Sep 21. Clin Exp Med. 2023. PMID: 36129558 Free PMC article. Review.
-
An investigation into the relationship between nutritional status, dietary intake, symptoms and health-related quality of life in children and young people with juvenile idiopathic arthritis: a systematic review and meta-analysis.BMC Pediatr. 2023 Jan 2;23(1):3. doi: 10.1186/s12887-022-03810-4. BMC Pediatr. 2023. PMID: 36593466 Free PMC article.
Cited by
-
Albumin and Gamma-Glutamyl Transferase as Biomarkers for Differentiating Systemic Juvenile Idiopathic Arthritis from Reactive Arthritis.J Inflamm Res. 2025 Jun 12;18:7671-7682. doi: 10.2147/JIR.S522233. eCollection 2025. J Inflamm Res. 2025. PMID: 40529895 Free PMC article.
-
Clinical Yield of Acute Inflammatory Markers in the Pediatric Emergency Department.Clin Pediatr (Phila). 2025 May;64(4):583-593. doi: 10.1177/00099228241283280. Epub 2024 Sep 24. Clin Pediatr (Phila). 2025. PMID: 40501008 Free PMC article.
References
-
- Manners P.J., Bower C. Worldwide prevalence of juvenile arthritis why does it vary so much? J. Rheumatol. 2002;29:1520–1530. - PubMed
-
- Petty R.E., Southwood T.R., Manners P., Baum J., Glass D.N., Goldenberg J., He X., Maldonado-Cocco J., Orozco-Alcala J., Prieur A.M., et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001. J. Rheumatol. 2004;31:390–392. - PubMed
-
- Low J.M., Chauhan A.K., Kietz D.A., Daud U., Pepmueller P.H., Moore T.L. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. J. Rheumatol. 2004;31:1829–1833. - PubMed
-
- Vehe R.K., Begovich A.B., Nepom B.S. HLA susceptibility genes in rheumatoid factor ositive juvenile rheumatoid arthritis. J. Rheumatol. 1990;26:11–15. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
